Cleared Traditional

K040966 - MODIFICATION TO CAREMATIX WELLNESS SYSTEM

K040966 is the FDA 510(k) clearance for MODIFICATION TO CAREMATIX WELLNESS SYSTEM by Carematix, Inc.. It is a Class 2 Cardiovascular device (product code DRG) cleared through the Traditional 510(k) pathway after a 49-day FDA review.

K040966 · Carematix, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2004
Decision
49d
Days
Class 2
Risk

K040966 is an FDA 510(k) clearance for the MODIFICATION TO CAREMATIX WELLNESS SYSTEM. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Carematix, Inc. (Chicago, US). The FDA issued a Cleared decision on June 2, 2004 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Carematix, Inc. devices

Submission Details

510(k) Number K040966 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 14, 2004
Decision Date June 02, 2004
Days to Decision 49 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 125d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 72
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K040966.
MOTIVA MONITOR DEVICE CONNECTIVITY, MODEL# 453564036921
K071564 · Philips Medical Systems · Aug 2007
MULTIPLE PATIENT RECEIVER, MODEL ORG-9700A
K071058 · Nihon Kohden America, Inc. · Jun 2007
THE PHILIPS MP20, MP30, MP40, MP50, MP60, MP70, AND MP90 INTELLIVUE PATIENT MONITORS, WITH 802.11 WIRELESS LAN
K052961 · Philips Medical Systems · Nov 2005
THE M3810A PHILIPS TELEMONITORING SYSTEM WITH M3812B TELESTATION (M310A/12B)
K023749 · Philips Medical Systems · Nov 2002
MODIFICATION OF: PHYSIOLOGICAL SIGNAL TRANSMITTER AND RECEIVER, MODEL 3810A
K993169 · Hewlett-Packard Co. · Dec 1999
AMBULATORY X-12 TELEMETRY MODULE
K974149 · Mortara Instrument, Inc. · Jan 1998